In this strategy, agents targeting ACC1, ACC2, and DGAT2 are in phase II clinical trials for the treatment of T2DM and nonalcoholic steatohepatitis (Table 1) [171]
Although significant progress has been made in elucidating the molecular and cellular mechanisms underlying drug-induced neurotoxicity, key questions remain
Figure 7 Measurement of the cytosolic E GSH in severely glutathione-deficient rml1 mutants GSH Conventional roGFP1 and roGFP2 are highly reduced when expressed in the cytosol of non-stressed cells (Meyer et al., E GSH
In clinical trials of semaglutide injection for type 2 diabetes mellitus (T2DM), cholelithiasis was reported in 1.5% and 0.4% of patients-treated with semaglutide 0.5 mg and 1 mg subcutaneous injection, respectively
Patients in the cysteamine group were instructed to maintain the cream on their skin for 15 minutes on the first night, followed by facial washing
The next day the dishes were repeatedly washed by PBS and stained with Alexa Fluor 488 and 555 Conjugate secondary antibodies (antirabbit, anti-mouse, 1:500